---
category: news
title: "'Cutting-edge science': OCD drug designed by artificial intelligence"
excerpt: "Two pharmaceutical companies have embarked on a brave new world, having begun human testing for the first time on a drug treatment for obsessive-compulsive disorder designed by artificial intelligence. British startup Exscientia and Japanâ€™s Sumitomo Dainippon Pharma used artificial intelligence to create the drug in less than 12 months ..."
publishedDateTime: 2020-02-07T03:34:00Z
webUrl: "https://www.washingtontimes.com/news/2020/feb/6/exscientia-ocd-drug-designed-artificial-intelligen/"
type: article
quality: 39
heat: 39
published: false

provider:
  name: Washington Times
  domain: washingtontimes.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://twt-thumbs.washtimes.com/media/image/2020/02/06/AP639348897898_c0-216-5184-3240_s1200x700.jpg?48c42b2789ee0d08ce9a91ab8317603cc81a12f8"
    width: 1200
    height: 700
    title: "'Cutting-edge science': OCD drug designed by artificial intelligence"

secured: "XeuSy/+a4vPzj7FV8dv1SZkEg7Xa5HwmGOS7Urb7FCOIcT2TanVJz8aGpArJpJxy1kb+qm3rBSyVW/zG7OFl52yJCxPzM1MdDPoF6ABl7pt14VaPYKBS7J5SpOZCG9L6jsy3pBN3u6C1xZ+bQN9+OVpWDf/AzTmp5pxftJ8V6rKbHZXKOjq97/StMBpjH0lohM21SusTSuijnlMHNSJ1p7iuOJjuEXyqMAZJia4V5XMdJTYbQWyTB160TaDTl5x81t6SASUdp/k9GC/MZ2OPhYg5Z1rktaLVKlyicZJnz6D3PQDkedwsXBibIhkOX79kNUSBvvYHGPfgswDGAKQsWQtGJ9v2fnvqRQ40pL0k4nL64npUyx/Hv6W8jNpnpx12QMqLSRqGTlwLNyTxZFALDhfW0pOxQ1MD+x+a19iEXbI/c9DBhBlcxAg3FNoJRYsu/iu9XB2n4oGtQqHkj1imIKrKDmXvNmYbjj0CuFChx3Y=;NLs13ANnfUU6HjbmuQO6Qg=="
---

